Details for 2019843524

Up to date per 04.04.2026

Actions

Title / Product Name

KOMBINATIONSPRODUKT AUS BCL-2-INHIBITOR UND CHEMOTHERAPEUTIKUM UND VERWENDUNG DAVON ZUR VORBEUGUNG UND/ODER BEHANDLUNG VON KRANKHEITEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019843524

EP Publication Number

3672595

E-Number

1411957

Language

PCT Number

CN19097081

Publication Date

01.07.2020 A

21.07.2021 B1

Registration Date

21.07.2021

AT Publication Date

15.08.2021

Application Date

22.07.2019

Registration Number

Priorities

31.07.2018

201810862169

IPC

A61K 31/4745 20060101AFI20210409BHEP

Maximum Duration of Protection

22.07.2039

Owner

Ascentage Pharma (Suzhou) Co., Ltd.Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215000CN

Representative

No representatives present

Inventor

YANG, DajunUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

ZHAI, YifanUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

WANG, GuangfengUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN